Interview with our CEO at

Interview with

Interview with our CEO at

Nutrient media for the development of regenerative therapies

In the latest interview at, our CEO Dr. Hatim Hemeda talked about the history and background idea of PL BioScience to develop nutrient media for the development of regenerative therapies.

As a young life science company we develop, produce and distribute Human Platelet Lysate (HPL) as a cell culture medium. The goal is to create an animal-free and qualitatively superior alternative to the market standard, which is based on blood from fetal calves (FBS). 

Read more about PL BioScience is a leading portal for life sciences and pharmaceuticals

At the platform users from the life science and pharmaceutical industry, research and science find the latest news and events in these markets. The user of can choose between four languages and read about trends and technology in laboratories, bioprocesses or production. Additionally, reports about offers for further education, specialties and  knowledge of a product and business interview with experts.

Read more about here

Challenges to solve and visions to chase

When founding and building up a company there are of course challenges to face but also visions to face and successes to celebrate. One of these challenging but also rewarding times for our CEO was the starting times of PL BioScience:

We have grown organically, with everything that goes with it in the first few years: Long working days with many cups of coffee, a small team that lends a hand in all areas and values ​​the hands-on mentality. It was an exciting time with many development processes. Our perseverance and team spirit was rewarded: Recently, we were able to win well-known investors who support us with financial resources and their industry know-how. It is an indescribable feeling that not only our customers and partners but also investors with industry experience are supporting us on our mission. We were able to expand our team and we succeeded in bundling our broad HPL portfolio into the platform technology ELAREM™, which we are constantly developing with a view to market requirements.” (source:

From the idea of commercial Human Platelet Lysate to a company

Furthermore, Dr. Hemeda gives an inside into the founding process with his business partner and friend Christian Wilkes. From the idea of an ethical and standardized cell culture medium that can replace the current “Gold Standard” (Fetal Bovine Serum) – to the first steps of an own company and hiring of a highly motivated interdisciplinary team.

Read the interesting answers to the questions on

  • How was your development process? What were the biggest challenges and setbacks?
  • What was the reaction of the market and industry?
  • Would you go this route again – or is there something you would do differently?
  • What can others learn from your start-up story?


Read the whole German interview
Any questions?
close slider

Any questions?

Please contact us:

+49 (0) 241 95719-100